Literature DB >> 24187138

Chemoproteomic analysis of intertissue and interspecies isoform diversity of AMP-activated protein kinase (AMPK).

Jiang Wu1, Dinesh Puppala, Xidong Feng, Mara Monetti, Amanda Lee Lapworth, Kieran F Geoghegan.   

Abstract

AMP-activated protein kinase (AMPK) is a heterotrimeric enzyme that senses and governs changes in the cellular energy balance represented by concentrations of AMP, ADP, and ATP. Each of its three chains (α, β, and γ) exists as either two or three subtypes, theoretically allowing up to 12 different forms of the complete enzyme. Tissue specificity in the distribution of AMPK subtypes is believed to underpin a range of biological functions for AMPK, a central regulator of metabolic function and response. It is of particular interest for drug discovery purposes to compare AMPK isoforms that are most prevalent in human liver and muscle with isoforms present in key preclinical species. To complement immunocapture/immunodetection methods, which for AMPK are challenged by sequence similarities and difficulties of obtaining accurate relative quantitation, AMPK was captured from lysates of a range of cells and tissues using the ActivX ATP probe. This chemical probe covalently attaches desthiobiotin to one or more conserved lysyl residues in the ATP-binding sites of protein kinases, including AMPK, while also labeling a wide range of ATP-utilizing proteins. Affinity-based recovery of labeled proteins followed by gel-based fractionation of the captured sample was followed by proteomic characterization of AMPK polypeptides. In agreement with transcript-based analysis and previous indications from immunodetection, the results indicated that the predominant AMPK heterotrimer in human liver is α1β2γ1 but that dog and rat livers mainly contain the α1β1γ1 and α2β1γ1 forms, respectively. Differences were not detected between the AMPK profiles of normal and diabetic human liver tissues.

Entities:  

Keywords:  AMP-activated Kinase (AMPK); Chemical Biology; Chemical Modification; Drug Discovery; Mass Spectrometry (MS)

Mesh:

Substances:

Year:  2013        PMID: 24187138      PMCID: PMC3861640          DOI: 10.1074/jbc.M113.508747

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  60 in total

1.  Robust estimators for expression analysis.

Authors:  Earl Hubbell; Wei-Min Liu; Rui Mei
Journal:  Bioinformatics       Date:  2002-12       Impact factor: 6.937

2.  Highly reproducible label free quantitative proteomic analysis of RNA polymerase complexes.

Authors:  Amber L Mosley; Mihaela E Sardiu; Samantha G Pattenden; Jerry L Workman; Laurence Florens; Michael P Washburn
Journal:  Mol Cell Proteomics       Date:  2010-11-03       Impact factor: 5.911

Review 3.  Activity-based protein profiling: from enzyme chemistry to proteomic chemistry.

Authors:  Benjamin F Cravatt; Aaron T Wright; John W Kozarich
Journal:  Annu Rev Biochem       Date:  2008       Impact factor: 23.643

4.  Predominant alpha2/beta2/gamma3 AMPK activation during exercise in human skeletal muscle.

Authors:  J B Birk; J F P Wojtaszewski
Journal:  J Physiol       Date:  2006-10-12       Impact factor: 5.182

Review 5.  Targeting AMP-activated protein kinase as a novel therapeutic approach for the treatment of metabolic disorders.

Authors:  B Viollet; R Mounier; J Leclerc; A Yazigi; M Foretz; F Andreelli
Journal:  Diabetes Metab       Date:  2007-11-07       Impact factor: 6.041

6.  Mass spectrometry based method to increase throughput for kinome analyses using ATP probes.

Authors:  F E McAllister; M Niepel; W Haas; E Huttlin; P K Sorger; S P Gygi
Journal:  Anal Chem       Date:  2013-04-22       Impact factor: 6.986

7.  AMPK beta subunit targets metabolic stress sensing to glycogen.

Authors:  Galina Polekhina; Abhilasha Gupta; Belinda J Michell; Bryce van Denderen; Sid Murthy; Susanne C Feil; Ian G Jennings; Duncan J Campbell; Lee A Witters; Michael W Parker; Bruce E Kemp; David Stapleton
Journal:  Curr Biol       Date:  2003-05-13       Impact factor: 10.834

8.  Structure of mammalian AMPK and its regulation by ADP.

Authors:  Bing Xiao; Matthew J Sanders; Elizabeth Underwood; Richard Heath; Faith V Mayer; David Carmena; Chun Jing; Philip A Walker; John F Eccleston; Lesley F Haire; Peter Saiu; Steven A Howell; Rein Aasland; Stephen R Martin; David Carling; Steven J Gamblin
Journal:  Nature       Date:  2011-03-13       Impact factor: 49.962

Review 9.  AMPK: a key sensor of fuel and energy status in skeletal muscle.

Authors:  D Grahame Hardie; Kei Sakamoto
Journal:  Physiology (Bethesda)       Date:  2006-02

10.  AMP is a true physiological regulator of AMP-activated protein kinase by both allosteric activation and enhancing net phosphorylation.

Authors:  Graeme J Gowans; Simon A Hawley; Fiona A Ross; D Grahame Hardie
Journal:  Cell Metab       Date:  2013-10-01       Impact factor: 27.287

View more
  17 in total

Review 1.  Evolving Lessons on the Complex Role of AMPK in Normal Physiology and Cancer.

Authors:  Biplab Dasgupta; Rishi Raj Chhipa
Journal:  Trends Pharmacol Sci       Date:  2015-12-20       Impact factor: 14.819

2.  Inhibition of AMP Kinase by the Protein Phosphatase 2A Heterotrimer, PP2APpp2r2d.

Authors:  Biny K Joseph; Hsing-Yin Liu; Jamie Francisco; Devanshi Pandya; Melissa Donigan; Christina Gallo-Ebert; Caroline Giordano; Adam Bata; Joseph T Nickels
Journal:  J Biol Chem       Date:  2015-02-18       Impact factor: 5.157

3.  Conformational heterogeneity of the allosteric drug and metabolite (ADaM) site in AMP-activated protein kinase (AMPK).

Authors:  Xin Gu; Michael D Bridges; Yan Yan; Parker W de Waal; X Edward Zhou; Kelly M Suino-Powell; H Eric Xu; Wayne L Hubbell; Karsten Melcher
Journal:  J Biol Chem       Date:  2018-09-11       Impact factor: 5.157

Review 4.  AMPK: restoring metabolic homeostasis over space and time.

Authors:  Elijah Trefts; Reuben J Shaw
Journal:  Mol Cell       Date:  2021-09-16       Impact factor: 19.328

Review 5.  Hypothalamic AMPK: a canonical regulator of whole-body energy balance.

Authors:  Miguel López; Rubén Nogueiras; Manuel Tena-Sempere; Carlos Diéguez
Journal:  Nat Rev Endocrinol       Date:  2016-05-20       Impact factor: 43.330

6.  Enhanced activation of cellular AMPK by dual-small molecule treatment: AICAR and A769662.

Authors:  Serge Ducommun; Rebecca J Ford; Laurent Bultot; Maria Deak; Luc Bertrand; Bruce E Kemp; Gregory R Steinberg; Kei Sakamoto
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-01-14       Impact factor: 4.310

7.  Modulation of de novo purine biosynthesis leads to activation of AMPK and results in improved glucose handling and insulin sensitivity.

Authors:  Satish Kumar Sadasivan; Balamuralikrishna Vasamsetti; Jaideep Singh; Nethra Siddaraju; Khaiser Mehdi Khan; Anup Mammen Oommen; Madanalli R Jagannath; Raghavendra Pralhada Rao
Journal:  J Diabetes Metab Disord       Date:  2014-04-24

8.  Probing the enzyme kinetics, allosteric modulation and activation of α1- and α2-subunit-containing AMP-activated protein kinase (AMPK) heterotrimeric complexes by pharmacological and physiological activators.

Authors:  Francis Rajamohan; Allan R Reyes; Richard K Frisbie; Lise R Hoth; Parag Sahasrabudhe; Rachelle Magyar; James A Landro; Jane M Withka; Nicole L Caspers; Matthew F Calabrese; Jessica Ward; Ravi G Kurumbail
Journal:  Biochem J       Date:  2015-12-03       Impact factor: 3.857

9.  Benzimidazole derivative small-molecule 991 enhances AMPK activity and glucose uptake induced by AICAR or contraction in skeletal muscle.

Authors:  Laurent Bultot; Thomas E Jensen; Yu-Chiang Lai; Agnete L B Madsen; Caterina Collodet; Samanta Kviklyte; Maria Deak; Arash Yavari; Marc Foretz; Sahar Ghaffari; Mohamed Bellahcene; Houman Ashrafian; Mark H Rider; Erik A Richter; Kei Sakamoto
Journal:  Am J Physiol Endocrinol Metab       Date:  2016-08-30       Impact factor: 4.310

Review 10.  Exercise in a Pill: The Latest on Exercise-Mimetics.

Authors:  Davide Guerrieri; Hyo Youl Moon; Henriette van Praag
Journal:  Brain Plast       Date:  2017-03-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.